{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:19:49Z","timestamp":1788527989221,"version":"build-2803163510"},"reference-count":271,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154408","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:30:11Z","timestamp":1786059011000},"page":"154408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanism-based biomarkers for early detection and plaque vulnerability assessment in atherosclerosis"],"prefix":"10.1016","volume":"833","author":[{"given":"Diksha","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samriddhi","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9917-0985","authenticated-orcid":false,"given":"Shubhdeep Singh","family":"Bandral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Altamash","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balakumar","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-9562","authenticated-orcid":false,"given":"Rajwinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154408_bib1","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib2","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/CM9.0000000000002839","article-title":"Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019","volume":"136","author":"Chen","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bbrc.2026.154408_bib3","article-title":"Prevalence of atherosclerotic coronary stenosis in asymptomatic North Indian population: a Post-mortem coronary angiography study","volume":"9","author":"Bansal","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib4","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.amjcard.2019.03.015","article-title":"Relation between cigarette smoking and heart failure (from the multiethnic study of atherosclerosis)","volume":"123","author":"Watson","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.0000126889.97626.B8","article-title":"High-density lipoprotein and cardiovascular risk","volume":"109","author":"Toth","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/labmed\/lmz032","article-title":"Non-high-density lipoprotein cholesterol and guidelines for cholesterol lowering in recent history","volume":"51","author":"Levinson","year":"2020","journal-title":"Lab. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib7","article-title":"Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity Medicine Association and the National Lipid Association 2024","volume":"10","author":"Bays","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.bbrc.2026.154408_bib8","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1186\/s12889-025-24921-4","article-title":"Interpretable machine learning model for cardiovascular disease risk prediction: a feature decomposition-based study","volume":"25","author":"Yu","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbrc.2026.154408_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0003319718776122","article-title":"The growing field of imaging of atherosclerosis in peripheral arteries","volume":"70","author":"Cattaneo","year":"2019","journal-title":"Angiology"},{"key":"10.1016\/j.bbrc.2026.154408_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1134097","article-title":"Diagnostics of atherosclerosis: overview of the existing methods","volume":"10","author":"Poznyak","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2026.154408_bib12","article-title":"Inflammation and cardiovascular disease: from mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7603\/s40602-016-0003-6","article-title":"PHA clinical practice guidelines for the diagnosis and management of patients with coronary heart disease","volume":"24","author":"Lazaro","year":"2014","journal-title":"ASEAN Heart J."},{"key":"10.1016\/j.bbrc.2026.154408_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.21037\/cdt.2015.11.07","article-title":"Noninvasive imaging modalities to visualize atherosclerotic plaques","volume":"6","author":"Shishikura","year":"2016","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.bbrc.2026.154408_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drudis.2019.09.005","article-title":"A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome","volume":"25","author":"Kiaie","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2026.154408_bib16","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.amjmed.2008.10.014","article-title":"Diagnosis of atherosclerosis by imaging","volume":"122","author":"Ibanez","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319884819","article-title":"Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers","volume":"10","author":"Nelson","year":"2019","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.bbrc.2026.154408_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s12350-016-0630-0","article-title":"Value-based imaging: combining coronary artery calcium with myocardial perfusion imaging","volume":"23","author":"Berman","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcct.2016.11.003","article-title":"SCCT\/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the society of cardiovascular computed tomography and society of thoracic radiology","volume":"11","author":"Hecht","year":"2016","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"10.1016\/j.bbrc.2026.154408_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.115.018524","article-title":"Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"133","author":"Blaha","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCIMAGING.112.000119","article-title":"Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent","volume":"6","author":"Bhavane","year":"2013","journal-title":"Circ., Cardiovasc. Imaging"},{"key":"10.1016\/j.bbrc.2026.154408_bib22","article-title":"Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles","volume":"14","author":"Zhang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.bbrc.2026.154408_bib23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/nbm.1065","article-title":"MRI of atherosclerosis in clinical trials","volume":"19","author":"Yuan","year":"2006","journal-title":"NMR Biomed."},{"key":"10.1016\/j.bbrc.2026.154408_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032008","article-title":"Ankle-brachial index and risk of sudden cardiac death in the community: the ARIC study","volume":"13","author":"Suzuki","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbrc.2026.154408_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309083","article-title":"Accuracy of ankle-brachial index in screening for peripheral arterial disease in people with diabetes","volume":"19","author":"Cerqueira","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154408_bib26","article-title":"A comprehensive review of clinical studies applying flow-mediated dilation","volume":"14","author":"Ahn","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.bbrc.2026.154408_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s44200-024-00057-5","article-title":"Flow-mediated dilatation: learning curve study with a novice operator","volume":"30","author":"Dhar","year":"2024","journal-title":"Artery Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pcad.2025.05.008","article-title":"Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience","volume":"92","author":"Bosco","year":"2025","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.bbrc.2026.154408_bib29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1186\/s12967-025-07432-z","article-title":"Translating the effect of dual lipid reduction with PCSK9 inhibitors on a mechanical vascular instrumental biomarker in familial hypercholesterolemia subjects","volume":"23","author":"Bosco","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319884819","article-title":"Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers","volume":"10","author":"Nelson","year":"2019","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.bbrc.2026.154408_bib31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCRESAHA.115.306247","article-title":"Imaging atherosclerosis","volume":"118","author":"Tarkin","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib32","first-page":"113","article-title":"Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation","volume":"3","author":"Nair","year":"2007","journal-title":"EuroIntervention"},{"key":"10.1016\/j.bbrc.2026.154408_bib33","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCRESAHA.114.302745","article-title":"Imaging plaques to predict and better manage patients with acute coronary events","volume":"114","author":"Garcia-Garcia","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib34","doi-asserted-by":"crossref","first-page":"755 e751","DOI":"10.1016\/j.ahj.2006.06.030","article-title":"Measurement of the thickness of the fibrous cap by optical coherence tomography","volume":"152","author":"Kume","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbrc.2026.154408_bib35","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/01.CIR.0000029927.92825.F6","article-title":"Characterization of human atherosclerosis by optical coherence tomography","volume":"106","author":"Yabushita","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrd2588","article-title":"Form to function: current and future roles for atherosclerosis imaging in drug development","volume":"7","author":"Lindsay","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.154408_bib37","doi-asserted-by":"crossref","first-page":"C92","DOI":"10.1016\/j.jacc.2005.12.045","article-title":"Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques","volume":"47","author":"Caplan","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jcmg.2008.06.001","article-title":"Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system","volume":"1","author":"Gardner","year":"2008","journal-title":"JACC, Cardiovasc. Imaging"},{"key":"10.1016\/j.bbrc.2026.154408_bib39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jcmg.2009.05.001","article-title":"In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study","volume":"2","author":"Waxman","year":"2009","journal-title":"JACC, Cardiovasc. Imaging"},{"key":"10.1016\/j.bbrc.2026.154408_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4244\/EIJV10I3A53","article-title":"Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT","volume":"10","author":"Roleder","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.bbrc.2026.154408_bib41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jcmg.2012.07.007","article-title":"Detection of high-risk atherosclerotic plaque: report of the NHLBI working group on current status and future directions","volume":"5","author":"Fleg","year":"2012","journal-title":"JACC, Cardiovasc. Imaging"},{"key":"10.1016\/j.bbrc.2026.154408_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/wjnm.WJNM_26_20","article-title":"Role of 18F-FDG positron emission tomography in carotid atherosclerotic plaque imaging: a systematic review","volume":"19","author":"Ravikanth","year":"2020","journal-title":"World J. Nucl. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib43","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.jacc.2009.12.061","article-title":"Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?","volume":"55","author":"Rudd","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2020.12.021","article-title":"Vascular imaging of atherosclerosis: strengths and weaknesses","volume":"319","author":"Mantella","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib45","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jacbts.2023.10.007","article-title":"Advances in clinical imaging of vascular inflammation","volume":"9","author":"West Henry","year":"2024","journal-title":"JACC, Basic Transl. Sci."},{"key":"10.1016\/j.bbrc.2026.154408_bib46","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib47","doi-asserted-by":"crossref","unstructured":"N.C.E.P.E.P.o. Detection, T.o.H.B.C.i. Adults, Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III), The Program2002. https:\/\/doi.org\/10.1161\/circ.106.25.3143.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.bbrc.2026.154408_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel","volume":"259","author":"Barter","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2007.01.071","article-title":"Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (the bogalusa heart study)","volume":"100","author":"Frontini","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib50","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","article-title":"Clinical utility of different lipid measures for prediction of coronary heart disease in men and women","volume":"298","author":"Ingelsson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2026.154408_bib51","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","article-title":"High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies","volume":"51","author":"van der Steeg","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation","volume":"31","author":"Brunzell","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2026.154408_bib53","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib54","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/aje\/kwk057","article-title":"Inflammation biomarkers and near-term death in older men","volume":"165","author":"Jenny","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-148-2-200801150-00003","article-title":"Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study","volume":"148","author":"Vidula","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib56","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","article-title":"Cystatin C and cardiovascular risk","volume":"55","author":"Taglieri","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbrc.2026.154408_bib57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCHEARTFAILURE.112.966960","article-title":"Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events, circulation","volume":"5","author":"Dupont","year":"2012","journal-title":"Heart Fail."},{"key":"10.1016\/j.bbrc.2026.154408_bib58","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2011.02.016","article-title":"Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease","volume":"216","author":"Urbonaviciene","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib60","first-page":"675","volume":"3","author":"Lee","year":"2010"},{"key":"10.1016\/j.bbrc.2026.154408_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2004.041889","article-title":"Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate","volume":"51","author":"Koenig","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbrc.2026.154408_bib62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.106.644286","article-title":"Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib63","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.2337\/db07-0539","article-title":"Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes","volume":"56","author":"Maahs","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2026.154408_bib64","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function--measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib65","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/diacare.28.4.838","article-title":"Estimation of glomerular filtration rate in diabetic subjects: cockcroft formula or modification of diet in renal disease study equation?","volume":"28","author":"Rigalleau","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2026.154408_bib66","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2026.154408_bib67","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/01.CIR.0000041661.63285.AE","article-title":"N-Terminal Pro-B\u2013Type natriuretic peptide and long-term mortality in acute coronary syndromes","volume":"106","author":"Omland","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2025.06.017","article-title":"Prognostic value of N-terminal prohormone B-type natriuretic peptide modified by renal function in patients with acute heart failure","volume":"140","author":"Zhu","year":"2025","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2026.154408_bib70","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction","volume":"50","author":"Thygesen","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib71","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute myocardial infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cca.2010.02.066","article-title":"High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: an initial foray","volume":"411","author":"Schulz","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2026.154408_bib73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurheartj\/ehq456","article-title":"Troponin elevation in coronary vs. non-coronary disease","volume":"32","author":"Agewall","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2026.154408_bib74","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/CIRCULATIONAHA.105.570762","article-title":"Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study","volume":"113","author":"Zethelius","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib75","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","article-title":"Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study","volume":"50","author":"Meuwese","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib76","series-title":"Mayo Clinic Proceedings","first-page":"159","article-title":"Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review","author":"Garza","year":"2007"},{"key":"10.1016\/j.bbrc.2026.154408_bib77","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1001\/archinte.165.21.2479","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"165","author":"Ballantyne","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib78","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib79","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib80","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"Sabatine","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib81","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2026.154408_bib82","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/ijms23010193","article-title":"Fibrinogen and atherosclerotic cardiovascular diseases-review of the literature and clinical studies","volume":"23","author":"Surma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154408_bib83","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/dna.2016.3496","article-title":"Characteristics and roles of exosomes in cardiovascular disease","volume":"36","author":"Zhang","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154408_bib84","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.thromres.2020.12.009","article-title":"Biomarker association with cardiovascular disease and mortality - the role of fibrinogen. A report from the NHANES study","volume":"198","author":"Pieters","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib85","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/01.CIR.0000025636.03561.EE","article-title":"Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men","volume":"106","author":"Pradhan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154408_bib87","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib88","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(01)06104-9","article-title":"Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis","volume":"358","author":"Malik","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.154408_bib89","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"I. Prevention of events with angiotensin converting enzyme inhibition trial, A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib90","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/hc3701.095949","article-title":"Circulating cell adhesion molecules and death in patients with coronary artery disease","volume":"104","author":"Blankenberg","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib91","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1055\/s-0037-1615019","article-title":"Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events","volume":"79","author":"Blann","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbrc.2026.154408_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","article-title":"Adhesion molecules and atherosclerosis","volume":"170","author":"Blankenberg","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib93","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1515\/CCLM.2001.136","article-title":"Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules","volume":"39","author":"Mazzone","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib94","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/01.CIR.93.7.1334","article-title":"Levels of soluble cell adhesion molecules in patients with dyslipidemia","volume":"93","author":"Hackman","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib95","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1067\/mhj.2000.108508","article-title":"Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles","volume":"140","author":"Lupattelli","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbrc.2026.154408_bib96","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/cs1040189","article-title":"Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia","volume":"104","author":"Jilma","year":"2003","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbrc.2026.154408_bib97","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0015-0282(98)00513-5","article-title":"Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women","volume":"71","author":"van Baal","year":"1999","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.bbrc.2026.154408_bib98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0049-3848(00)00382-0","article-title":"Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users","volume":"101","author":"Oger","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib99","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.ATV.15.8.1094","article-title":"Determinants of fibrin D-dimer in the Edinburgh artery study","volume":"15","author":"Lee","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2026.154408_bib100","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.numecd.2022.05.013","article-title":"Association of D-dimer with long-term prognosis in type 2 diabetes mellitus patients with acute coronary syndrome","volume":"32","author":"Zhou","year":"2022","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.bbrc.2026.154408_bib101","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12872-022-02531-x","article-title":"D-dimer as a predictor of cardiovascular outcomes in patients with diabetes mellitus","volume":"22","author":"Cheng","year":"2022","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.bbrc.2026.154408_bib102","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1050-1738(02)00182-2","article-title":"Coagulation pathways in atherothrombosis","volume":"12","author":"Khrenov","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib103","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154408_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00795-003-0212-5","article-title":"Expression of thrombomodulin in human aortic smooth muscle cells with special reference to atherosclerotic lesion types and age differences","volume":"36","author":"Yoshii","year":"2003","journal-title":"Med. Electron. Microsc."},{"key":"10.1016\/j.bbrc.2026.154408_bib105","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCULATIONAHA.109.907121","article-title":"Early atherosclerosis exhibits an enhanced procoagulant state","volume":"122","author":"Borissoff","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132999","article-title":"Fibrin clot properties in atherosclerotic vascular disease: from pathophysiology to clinical outcomes","volume":"10","author":"Zabczyk","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib107","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2020.06.003","article-title":"Tissue factor in atherosclerosis and atherothrombosis","volume":"307","author":"Grover","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib108","first-page":"861","article-title":"Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas","volume":"141","author":"Valenzuela","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2026.154408_bib109","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0037-1614017","article-title":"Human carotid artery smooth muscle cells rarely express \u03b1v\u03b23 integrin at sites of recent plaque rupture","volume":"84","author":"Ikari","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbrc.2026.154408_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115546","article-title":"Atherosclerosis and its related laboratory biomarkers","volume":"24","author":"Della Corte","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154408_bib111","doi-asserted-by":"crossref","first-page":"262","DOI":"10.12997\/jla.2024.13.3.262","article-title":"Emerging circulating biomarkers for enhanced cardiovascular risk prediction","volume":"13","author":"Lee","year":"2024","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.bbrc.2026.154408_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1310094","article-title":"The role of midkine in health and disease","volume":"14","author":"Neumaier","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154408_bib113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1253\/circj.CJ-17-0043","article-title":"Midkine promotes atherosclerotic plaque formation through its pro-inflammatory, angiogenic and anti-apoptotic functions in apolipoprotein E-knockout mice","volume":"82","author":"Takemoto","year":"2017","journal-title":"Circ. J."},{"key":"10.1016\/j.bbrc.2026.154408_bib114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cca.2021.07.024","article-title":"Midkine: a multifaceted driver of atherosclerosis","volume":"521","author":"Zhang","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2026.154408_bib115","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jvs.2007.12.037","article-title":"Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits","volume":"47","author":"Narita","year":"2008","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.bbrc.2026.154408_bib116","first-page":"A18948","article-title":"A clinical and biomarker scoring system to predict the presence of obstructive peripheral artery disease: results from the catheter sampled blood archive in cardiovascular diseases (CASABLANCA) study","volume":"136","author":"McCarthy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib117","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4103\/njcp.njcp_309_17","article-title":"Midkine levels and its relationship with atherosclerotic risk factors in essential hypertensive patients","volume":"21","author":"Guzel","year":"2018","journal-title":"Niger. J. Clin. Pract."},{"key":"10.1016\/j.bbrc.2026.154408_bib118","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib119","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2018.11.064","article-title":"A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family","volume":"508","author":"Maranghi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154408_bib120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00041433-200006000-00005","article-title":"ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins","volume":"11","author":"Oram","year":"2000","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2026.154408_bib121","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2021.04.002","article-title":"TIGAR mitigates atherosclerosis by promoting cholesterol efflux from macrophages","volume":"327","author":"Zhao","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib122","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.012587699","article-title":"The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL\/6 and apoE-knockout mice","volume":"99","author":"Joyce","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154408_bib123","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1253\/circj.CJ-19-0430","article-title":"Midkine inhibits cholesterol efflux by decreasing ATP-binding membrane cassette transport protein A1 via adenosine monophosphate-activated protein kinase\/Mammalian target of Rapamycin signaling in macrophages","volume":"84","author":"Ou","year":"2020","journal-title":"Circ. J."},{"key":"10.1016\/j.bbrc.2026.154408_bib124","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib126","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000955","article-title":"Performance of a clinical\/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus","volume":"6","author":"McCarthy","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.bbrc.2026.154408_bib127","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.ATV.0000148548.47755.22","article-title":"Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice","volume":"25","author":"Liu","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2026.154408_bib128","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.106.632273","article-title":"Midkine plays a protective role against cardiac ischemia\/reperfusion injury through a reduction of apoptotic reaction","volume":"114","author":"Horiba","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1442-200X.2009.02885.x","article-title":"Serum levels of Midkine in children and adolescents without malignant disease","volume":"52","author":"Lucas","year":"2010","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.bbrc.2026.154408_bib130","article-title":"Midkine, a potential link between obesity and insulin resistance","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154408_bib131","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","article-title":"Pentraxin 3 in Cardiovascular Disease","volume":"10","author":"Ristagno","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154408_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031474","article-title":"Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies","volume":"7","author":"Knoflach","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154408_bib133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/path.2314","article-title":"Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions","volume":"215","author":"Savchenko","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrc.2026.154408_bib134","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fimmu.2019.00712","article-title":"The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer","volume":"10","author":"Doni","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154408_bib135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10238-007-0118-y","article-title":"Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66 (ShcA) in pacemaker-implanted patients","volume":"7","author":"Bosutti*","year":"2007","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib136","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.atherosclerosis.2008.05.015","article-title":"Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors","volume":"202","author":"Alberti","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib137","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","article-title":"Macrophage diversity and polarization in atherosclerosis: a question of balance","volume":"29","author":"Mantovani","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2026.154408_bib138","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1194\/jlr.M200382-JLR200","article-title":"Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells","volume":"44","author":"Abderrahim-Ferkoune","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib139","doi-asserted-by":"crossref","first-page":"E1254","DOI":"10.1152\/ajpendo.00163.2011","article-title":"Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity","volume":"301","author":"Osorio-Conles","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2026.154408_bib140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","article-title":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease","volume":"51","author":"Marais","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.bbrc.2026.154408_bib141","series-title":"Introduction to Lipids and Lipoproteins","author":"Feingold","year":"2024"},{"key":"10.1016\/j.bbrc.2026.154408_bib142","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/biomedicines10071578","article-title":"Apolipoprotein A-II, a player in multiple processes and diseases","volume":"10","author":"Florea","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2026.154408_bib143","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpeds.2020.08.017","article-title":"Relationship of apolipoproteins with subclinical cardiovascular risk in youth","volume":"227","author":"Czeck","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbrc.2026.154408_bib144","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.atherosclerosis.2010.07.004","article-title":"The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study)","volume":"212","author":"Guardiola","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib145","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154408_bib146","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.3390\/ijms20225547","article-title":"MicroRNAs as potential biomarkers in atherosclerosis","volume":"20","author":"Churov","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154408_bib147","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fphys.2014.00015","article-title":"Atrial fibrillation and microRNAs","volume":"5","author":"Santulli","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib148","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.4161\/cc.8.13.8988","article-title":"Microvesicles: messengers and mediators of tumor progression","volume":"8","author":"Al-Nedawi","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2026.154408_bib149","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cvr\/cvs115","article-title":"Smooth muscle cell phenotypic switching in atherosclerosis","volume":"95","author":"Gomez","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154408_bib151","doi-asserted-by":"crossref","first-page":"H3052","DOI":"10.1152\/ajpheart.01355.2006","article-title":"HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway","volume":"292","author":"Gupta","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib152","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MOL.0000000000000219","article-title":"Endothelial and smooth muscle cell transformation in atherosclerosis","volume":"26","author":"Lao","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2026.154408_bib153","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.blre.2012.12.002","article-title":"Extracellular vesicles in physiological and pathological conditions","volume":"27","author":"Yuana","year":"2013","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbrc.2026.154408_bib154","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jcp.24344","article-title":"MicroRNA transport: a new way in cell communication","volume":"228","author":"Xu","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib155","volume":"4","author":"Oparil","year":"2018","journal-title":"Hypertension, Nat Rev Dis Primers"},{"key":"10.1016\/j.bbrc.2026.154408_bib156","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/HYPERTENSIONAHA.120.16064","article-title":"Therapeutic potential of extracellular vesicles in hypertension-associated kidney disease","volume":"77","author":"Martinez-Arroyo","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2026.154408_bib157","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01072-2019","article-title":"Circulating plasma exosomes in obstructive sleep apnoea and reverse dipping blood pressure","volume":"55","author":"Khalyfa","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2026.154408_bib158","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/hr.2016.163","article-title":"Macrophage-derived exosomes induce inflammatory factors in endothelial cells under hypertensive conditions","volume":"40","author":"Osada-Oka","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib159","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.bbrc.2018.06.075","article-title":"Plasma exosomes regulate systemic blood pressure in rats","volume":"503","author":"Otani","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154408_bib160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-5793(89)81679-5","article-title":"A putative protein of a growth specific cDNA from BALB\/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor","volume":"258","author":"Tominaga","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2026.154408_bib161","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1073\/pnas.86.15.5708","article-title":"Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen","volume":"86","author":"Klemenz","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154408_bib162","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.164.2.2008120","article-title":"Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation","volume":"164","author":"Oshikawa","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib163","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.09.021","article-title":"Soluble ST2 in heart failure","volume":"443","author":"Dieplinger","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2026.154408_bib164","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003188","article-title":"Soluble ST 2 for prediction of heart failure and cardiovascular death in an elderly, community\u2010dwelling population","volume":"5","author":"Parikh","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbrc.2026.154408_bib166","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3343\/alm.2017.37.2.137","article-title":"Comparison between soluble ST2 and high-sensitivity troponin I in predicting short-term mortality for patients presenting to the emergency department with chest pain","volume":"37","author":"Marino","year":"2017","journal-title":"Annals of laboratory medicine"},{"key":"10.1016\/j.bbrc.2026.154408_bib167","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diabres.2016.06.006","article-title":"Distribution and clinical association of plasma soluble ST2 during the development of type 2 diabetes","volume":"118","author":"Lin","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2026.154408_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-10-101","article-title":"Toll\/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction","volume":"10","author":"Fousteris","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2026.154408_bib169","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00592-018-1230-z","article-title":"Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects","volume":"56","author":"Cardellini","year":"2019","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.bbrc.2026.154408_bib170","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jacc.2008.07.042","article-title":"Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure","volume":"52","author":"Rehman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib171","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/jcdd4030009","article-title":"A multiparametric approach based on NT-proBNP, ST2, and Galectin3 for stratifying one year prognosis of chronic heart failure outpatients","volume":"4","author":"Grande","year":"2017","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.bbrc.2026.154408_bib172","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cardfail.2013.09.005","article-title":"Soluble ST2 serum concentration and renal function in heart failure","volume":"19","author":"Bayes-Genis","year":"2013","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bbrc.2026.154408_bib173","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/eci.12234","article-title":"Kidney function crucially affects B\u2010type natriuretic peptide (BNP), N\u2010terminal pro BNP and their relationship","volume":"44","author":"Takase","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2026.154408_bib174","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1309\/AJCP60HTPGIGFCNK","article-title":"The effect of renal dysfunction on BNP, NT-proBNP, and their ratio","volume":"133","author":"Srisawasdi","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbrc.2026.154408_bib175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/14017431.2019.1622770","article-title":"Effect of long-term remote ischemic conditioning on inflammation and cardiac remodeling","volume":"53","author":"Pryds","year":"2019","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.bbrc.2026.154408_bib176","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mvr.2018.11.009","article-title":"Evaluation of serum sST2 and sCD40L values in patients with microvascular angina","volume":"122","author":"Aslan","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib177","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2026.154408_bib178","first-page":"145","article-title":"Teste com ST2 sol\u00favel: um biomarcador promissor no tratamento da insufici\u00eancia card\u00edaca","volume":"106","author":"Villacorta","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib179","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1373\/clinchem.2012.192153","article-title":"Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study","volume":"58","author":"Coglianese","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbrc.2026.154408_bib180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2009.08.010","article-title":"Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay","volume":"409","author":"Dieplinger","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2026.154408_bib181","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/ehf2.12673","article-title":"Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients","volume":"7","author":"Crnko","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.bbrc.2026.154408_bib182","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2020.04.011","article-title":"Soluble ST2: a complex and diverse role in several diseases","volume":"507","author":"Homsak","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2026.154408_bib183","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF03194597","article-title":"The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism","volume":"47","author":"Chmurzynska","year":"2006","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.bbrc.2026.154408_bib184","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/heartjnl-2013-305253","article-title":"Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction","volume":"100","author":"Liebetrau","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.bbrc.2026.154408_bib185","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00441-004-0881-y","article-title":"Heart-type fatty acid binding proteins are upregulated during terminal differentiation of mouse cardiomyocytes, as revealed by proteomic analysis","volume":"316","author":"Tang","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib186","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yexcr.2014.02.015","article-title":"Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia","volume":"323","author":"Wang","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib187","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ihj.2015.07.030","article-title":"Heart-type fatty acid-binding protein (H-FABP) and coronary heart disease","volume":"68","author":"Das","year":"2016","journal-title":"Indian Heart J."},{"key":"10.1016\/j.bbrc.2026.154408_bib188","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s11033-016-4026-7","article-title":"Tissue expression analysis, cloning and characterization of the 5'-regulatory region of the bovine FABP3 gene","volume":"43","author":"Li","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2026.154408_bib189","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1523\/JNEUROSCI.1285-18.2018","article-title":"FABP3 in the anterior cingulate cortex modulates the methylation status of the glutamic acid Decarboxylase(67) promoter region","volume":"38","author":"Yamamoto","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2026.154408_bib190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacc.2012.08.1003","article-title":"The circulating level of FABP3 is an indirect biomarker of microRNA-1","volume":"61","author":"Varrone","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib191","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.HYP.30.5.1041","article-title":"Cardiac myocyte membrane wounding in the abruptly pressure-overloaded rat heart under high wall stress","volume":"30","author":"Fischer","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2026.154408_bib192","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/aps.2018.37","article-title":"Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis","volume":"39","author":"Ye","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2026.154408_bib193","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1253\/jcj.64.18","article-title":"Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery","volume":"64","author":"Hayashida","year":"2000","journal-title":"Jpn. Circ. J."},{"key":"10.1016\/j.bbrc.2026.154408_bib194","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4615-3514-0_22","article-title":"Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man","author":"Kleine","year":"1992","journal-title":"Lipid Metabolism in the Healthy and Disease Heart"},{"key":"10.1016\/j.bbrc.2026.154408_bib195","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/clinchem\/43.8.1372","article-title":"Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction","volume":"43","author":"Ishii","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbrc.2026.154408_bib196","first-page":"167","article-title":"Fatty acid-binding protein as the earliest available plasma marker of acute myocardial injury","volume":"25","author":"Glatz","year":"2002","journal-title":"J. Clin. Ligand Assay"},{"key":"10.1016\/j.bbrc.2026.154408_bib197","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/CCLM.2000.034","article-title":"Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB","volume":"38","author":"Okamoto","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib198","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/clinchem\/46.5.718","article-title":"Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction","volume":"46","author":"Ghani","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbrc.2026.154408_bib199","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib200","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2403081","article-title":"Role of the Stress- and inflammation-induced cytokine GDF-15 in cardiovascular diseases: from basic research to clinical relevance","volume":"24","author":"Schwarz","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib201","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.1038\/s41467-024-51078-2","article-title":"Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH","volume":"15","author":"L\u2019homme","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154408_bib202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001765","article-title":"Fetuin-A induces cytokine expression and suppresses adiponectin production","volume":"3","author":"Hennige","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154408_bib203","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1681\/ASN.2016080919","article-title":"Growth differentiation Factor-15 and risk of CKD progression","volume":"28","author":"Nair","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2026.154408_bib204","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2018.03.025","article-title":"GDF-15, Galectin 3, soluble ST2, and risk of mortality and cardiovascular events in CKD","volume":"72","author":"Tuegel","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbrc.2026.154408_bib206","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvs135","article-title":"The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles","volume":"95","author":"Lacolley","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib207","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jvs.2006.09.051","article-title":"Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy","volume":"45","author":"Hellings","year":"2007","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.bbrc.2026.154408_bib208","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijcard.2017.03.101","article-title":"Circulating GDF-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis","volume":"241","author":"Gohar","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib209","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness","volume":"114","author":"Durham","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00441-004-0986-3","article-title":"Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions","volume":"318","author":"Schlittenhardt","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib211","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20100370","article-title":"Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis","volume":"208","author":"de Jager","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib212","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/01.CIR.97.21.2110","article-title":"Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women","volume":"97","author":"Burke","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2016.09.014","article-title":"Effects of cigarette smoking on cardiovascular-related protein profiles in two community-based cohort studies","volume":"254","author":"Huang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib214","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrcardio.2013.8","article-title":"The biology behind the atherothrombotic effects of cigarette smoke","volume":"10","author":"Csordas","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.acc.2024.04.005","article-title":"suPAR in cardiovascular disease","volume":"121","author":"Montecillo","year":"2024","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.bbrc.2026.154408_bib216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-018-0141-8","article-title":"Healthy lifestyles reduce suPAR and mortality in a Danish general population study","volume":"16","author":"Haupt","year":"2019","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.bbrc.2026.154408_bib217","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/gerona\/glaa178","article-title":"Association between elevated suPAR, a new biomarker of inflammation, and accelerated aging","volume":"76","author":"Rasmussen","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.bbrc.2026.154408_bib218","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/STROKEAHA.113.003305","article-title":"Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease","volume":"45","author":"Persson","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.bbrc.2026.154408_bib219","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","article-title":"CRP and suPAR are differently related to anthropometry and subclinical organ damage","volume":"167","author":"Lyngbaek","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.mbc.0000114441.59147.56","article-title":"Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions","volume":"15","author":"Steins","year":"2004","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.bbrc.2026.154408_bib221","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib222","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0971-9784.179588","article-title":"Soluble urokinase plasminogen activation receptor--An emerging new biomarker of cardiovascular disease and critical illness","volume":"19","author":"Cyrille","year":"2016","journal-title":"Ann. Card Anaesth."},{"key":"10.1016\/j.bbrc.2026.154408_bib223","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.amjcard.2012.08.008","article-title":"Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention","volume":"110","author":"Lyngbaek","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib224","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2014.12.025","article-title":"Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease","volume":"239","author":"Mekonnen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00041433-199906000-00005","article-title":"Lipoprotein(a): intrigues and insights","volume":"10","author":"Hobbs","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2026.154408_bib226","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jacc.2012.06.057","article-title":"Lipoprotein-associated phospholipase A2 bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up","volume":"60","author":"Rallidis","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib227","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9343(00)00652-5","article-title":"Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men","volume":"110","author":"Seed","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib228","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00043798-200110000-00011","article-title":"Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease","volume":"8","author":"Katsouras","year":"2001","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.bbrc.2026.154408_bib229","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/339303a0","article-title":"Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis","volume":"339","author":"Hajjar","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154408_bib230","first-page":"2027","article-title":"Lipoprotein (a) is a potent chemoattractant for human peripheral monocytes","volume":"90","author":"Syrovets","year":"1997","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.bbrc.2026.154408_bib231","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.97.8.721","article-title":"Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells","volume":"97","author":"Takami","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib232","doi-asserted-by":"crossref","first-page":"46864","DOI":"10.1074\/jbc.M107943200","article-title":"Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain","volume":"276","author":"Klezovitch","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154408_bib233","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cardiores.2004.03.005","article-title":"Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase","volume":"63","author":"Tsironis","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib234","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.ATV.9.5.593","article-title":"Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation","volume":"9","author":"Cushing","year":"1989","journal-title":"Arteriosclerosis: An Official Journal of the American Heart Association, Inc."},{"key":"10.1016\/j.bbrc.2026.154408_bib235","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-2275(20)42092-9","article-title":"Quantification of apo[a] and apoB in human atherosclerotic lesions","volume":"32","author":"Pepin","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib236","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0021-9150(96)05872-8","article-title":"PAF-acetylhydrolase activity on Lp (a) before and during Cu2+-induced oxidative modification in vitro","volume":"125","author":"Karabina","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib237","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1050-1738(01)00098-6","article-title":"Evidence for a role of phospholipid oxidation products in atherogenesis","volume":"11","author":"Berliner","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib238","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.bbrc.2026.154408_bib239","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2004.07.030","article-title":"Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease","volume":"177","author":"Tsironis","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154408_bib240","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1210\/jc.2002-021444","article-title":"Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors","volume":"89","author":"Becker","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2026.154408_bib241","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.154408_bib242","first-page":"1605","article-title":"Procalcitonin increase after endotoxin injection in normal subjects","volume":"79","author":"Dandona","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2026.154408_bib243","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.ATV.19.10.2355","article-title":"Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries","volume":"19","author":"Erren","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2026.154408_bib244","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.CCM.0000134404.63292.71","article-title":"Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes","volume":"32","author":"Linscheid","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbrc.2026.154408_bib245","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1210\/jc.2010-0305","article-title":"Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome","volume":"95","author":"Abbasi","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2026.154408_bib246","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/17482940701534800","article-title":"Procalcitonin in acute myocardial infarction","volume":"10","author":"Kafkas","year":"2008","journal-title":"Acute Card. Care"},{"key":"10.1016\/j.bbrc.2026.154408_bib247","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/147323001003800106","article-title":"Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome","volume":"38","author":"Ataoglu","year":"2010","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib248","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/13547501003675084","article-title":"Procalcitonin as a prognostic marker in patients with acute myocardial infarction","volume":"15","author":"Kelly","year":"2010","journal-title":"Biomarkers"},{"key":"10.1016\/j.bbrc.2026.154408_bib249","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clinbiochem.2018.07.006","article-title":"Diagnostic and prognostic properties of procalcitonin in patients with acute dyspnea: data from the ACE 2 study","volume":"59","author":"Berge","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbrc.2026.154408_bib250","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc13181","article-title":"Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4,698 cases","volume":"18","author":"Wang","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbrc.2026.154408_bib251","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.mol.0000162331.92913.b6","article-title":"Atherosclerosis: cell biology and lipoproteins","volume":"16","author":"Daugherty","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2026.154408_bib252","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2026.154408_bib253","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2337\/diabetes.53.11.2950","article-title":"Leukocyte-derived myeloperoxidase amplifies high-glucose\u2014Induced endothelial dysfunction through interaction with high-glucose\u2014Stimulated, vascular non\u2014Leukocyte-derived reactive oxygen species","volume":"53","author":"Zhang","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2026.154408_bib254","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCULATIONAHA.108.813998","article-title":"Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques","volume":"120","author":"Ronald","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib255","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9440(10)64036-9","article-title":"Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes","volume":"158","author":"Sugiyama","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2026.154408_bib256","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.RES.85.10.950","article-title":"Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo","volume":"85","author":"Hazen","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.154408_bib257","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.0000140262.20831.8F","article-title":"Serum myeloperoxidase levels independently predict endothelial dysfunction in humans","volume":"110","author":"Vita","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib258","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/CP9.0000000000000097","article-title":"The role of myeloperoxidase as a biomarker in atherosclerotic cardiovascular disease","volume":"9","author":"Amirfakhryan","year":"2024","journal-title":"Cardiology Plus"},{"key":"10.1016\/j.bbrc.2026.154408_bib259","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0735-1097(02)81147-0","article-title":"Role of circulating myeloperoxidase positive monocytes and neutrophils in occlusive coronary thrombi","volume":"39","author":"Burke","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib260","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/01.CIR.0000042674.89762.20","article-title":"Neutrophil infiltration of culprit lesions in acute coronary syndromes","volume":"106","author":"Naruko","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.154408_bib261","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2026.154408_bib262","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ajcn\/72.2.333","article-title":"Homocysteine and cardiovascular risk12","volume":"72","author":"Scott","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbrc.2026.154408_bib263","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.avsg.2011.05.047","article-title":"Relationship between plasma homocysteine and the morphological and immunohistochemical study of carotid plaques in patients with carotid stenosis over 70%","volume":"26","author":"Alvarez","year":"2012","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.bbrc.2026.154408_bib264","doi-asserted-by":"crossref","DOI":"10.1038\/srep37361","article-title":"Homocysteine and its relationship to asymptomatic carotid stenosis in a Chinese community population","volume":"6","author":"Jia","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154408_bib265","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.2436385100","article-title":"The atherogenic effect of excess methionine intake","volume":"100","author":"Troen","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154408_bib266","doi-asserted-by":"crossref","unstructured":"D.M. Kerins, M.J. Koury, A. Capdevila, S. Rana, C. Wagner, Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine, Am. J. Clin. Nutr. DOI: 10.1093\/ajcn\/74.6.723.","DOI":"10.1093\/ajcn\/74.6.723"},{"key":"10.1016\/j.bbrc.2026.154408_bib267","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41569-022-00769-8","article-title":"Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research","volume":"20","author":"Gaba","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2026.154408_bib268","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2026.154408_bib269","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154408_bib270","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2026.154408_bib271","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/CP9.0000000000000097","article-title":"The role of myeloperoxidase as a biomarker in atherosclerotic cardiovascular disease","volume":"9","author":"New","year":"2024","journal-title":"Cardiology Plus"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:47:18Z","timestamp":1788526038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":271,"alternative-id":["S0006291X26011721"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154408","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism-based biomarkers for early detection and plaque vulnerability assessment in atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154408"}}